Log in

NYSE:RMAXRe/Max Stock Price, Forecast & News

$30.60
+0.17 (+0.56 %)
(As of 07/10/2020 04:00 PM ET)
Add
Compare
Today's Range
$30.28
Now: $30.60
$31.08
50-Day Range
$25.12
MA: $30.49
$34.37
52-Week Range
$14.40
Now: $30.60
$40.78
Volume59,400 shs
Average Volume108,872 shs
Market Capitalization$548.05 million
P/E Ratio23.54
Dividend Yield2.89%
Beta1.61
RE/MAX Holdings, Inc. operates as a franchisor of real estate and mortgage brokerage services in the United States, Canada, and internationally. The company offers its real estate franchise services under the RE/MAX brand name; and mortgage brokerage services under the Motto Mortgage brand. It also provides real estate technology solutions. The company was founded in 1973 and is headquartered in Denver, Colorado.
Read More
Re/Max logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.4Community Rank: 2.3Dividend Strength: 3.3Insider Behavior: 1.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.06 out of 5 stars


Industry, Sector and Symbol

Industry Real estate agents & managers
Sub-IndustryN/A
SectorFinance
CUSIPN/A
Phone303-770-5531

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$282.29 million
Cash Flow$4.57 per share
Book Value$5.51 per share

Profitability

Net Income$25.04 million

Miscellaneous

Employees500
Market Cap$548.05 million
Next Earnings Date8/6/2020 (Confirmed)
OptionableOptionable

Receive RMAX News and Ratings via Email

Sign-up to receive the latest news and ratings for RMAX and its competitors with MarketBeat's FREE daily newsletter.

Re/Max (NYSE:RMAX) Frequently Asked Questions

How has Re/Max's stock been impacted by COVID-19 (Coronavirus)?

Re/Max's stock was trading at $24.88 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, RMAX stock has increased by 23.0% and is now trading at $30.60. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Re/Max?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Re/Max in the last year. There are currently 1 hold rating and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Re/Max.

When is Re/Max's next earnings date?

Re/Max is scheduled to release its next quarterly earnings announcement on Thursday, August 6th 2020. View our earnings forecast for Re/Max.

How can I listen to Re/Max's earnings call?

Re/Max will be holding an earnings conference call on Thursday, August 6th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Re/Max's earnings last quarter?

Re/Max Holdings Inc (NYSE:RMAX) issued its quarterly earnings data on Wednesday, May, 6th. The financial services provider reported $0.39 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.28 by $0.11. The financial services provider had revenue of $70.30 million for the quarter, compared to the consensus estimate of $70.26 million. Re/Max had a return on equity of 49.97% and a net margin of 8.27%. The business's revenue for the quarter was down 1.3% on a year-over-year basis. During the same period in the previous year, the firm posted $0.48 earnings per share. View Re/Max's earnings history.

How often does Re/Max pay dividends? What is the dividend yield for Re/Max?

Re/Max declared a quarterly dividend on Tuesday, May 5th. Stockholders of record on Tuesday, May 19th will be given a dividend of $0.22 per share on Tuesday, June 2nd. This represents a $0.88 dividend on an annualized basis and a yield of 2.88%. The ex-dividend date of this dividend is Monday, May 18th. View Re/Max's dividend history.

What price target have analysts set for RMAX?

6 brokerages have issued 1 year price targets for Re/Max's shares. Their forecasts range from $32.00 to $40.00. On average, they expect Re/Max's stock price to reach $36.40 in the next twelve months. This suggests a possible upside of 19.0% from the stock's current price. View analysts' price targets for Re/Max.

Has Re/Max been receiving favorable news coverage?

News headlines about RMAX stock have been trending neutral this week, InfoTrie Sentiment Analysis reports. InfoTrie ranks the sentiment of media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Re/Max earned a daily sentiment score of 0.2 on InfoTrie's scale. They also assigned press coverage about the financial services provider a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the next several days. View the latest news about Re/Max.

Are investors shorting Re/Max?

Re/Max saw a decline in short interest in June. As of June 15th, there was short interest totaling 643,300 shares, a decline of 7.9% from the May 31st total of 698,600 shares. Based on an average daily volume of 176,200 shares, the days-to-cover ratio is presently 3.7 days. Approximately 3.7% of the shares of the company are sold short. View Re/Max's Current Options Chain.

Who are some of Re/Max's key competitors?

What other stocks do shareholders of Re/Max own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Re/Max investors own include Cisco Systems (CSCO), Walt Disney (DIS), Starbucks (SBUX), Weyerhaeuser (WY), eXp World (EXPI), JPMorgan Chase & Co. (JPM), NVIDIA (NVDA), Trade Desk (TTD), Zillow Group (Z) and AbbVie (ABBV).

Who are Re/Max's key executives?

Re/Max's management team includes the following people:
  • Mr. David L. Liniger, Co-Founder & Non-Exec. Chairman (Age 73)
  • Mr. Adam M. Contos, CEO & Director (Age 47)
  • Ms. Gail A. Liniger, Co-Founder & Vice Chair (Age 73)
  • Ms. Karri R. Callahan, Chief Financial Officer (Age 41)
  • Ms. Serene M. Smith, Chief of Staff & COO (Age 40)

What is Re/Max's stock symbol?

Re/Max trades on the New York Stock Exchange (NYSE) under the ticker symbol "RMAX."

Who are Re/Max's major shareholders?

Re/Max's stock is owned by many different retail and institutional investors. Top institutional investors include Confluence Investment Management LLC (2.83%) and Dalton Greiner Hartman Maher & Co. (0.55%). Company insiders that own Re/Max stock include Daniel J Predovich, David L Liniger, Gail A Liniger and Serene M Smith. View institutional ownership trends for Re/Max.

Which institutional investors are selling Re/Max stock?

RMAX stock was sold by a variety of institutional investors in the last quarter, including Confluence Investment Management LLC. View insider buying and selling activity for Re/Max.

Which institutional investors are buying Re/Max stock?

RMAX stock was purchased by a variety of institutional investors in the last quarter, including Dalton Greiner Hartman Maher & Co.. Company insiders that have bought Re/Max stock in the last two years include David L Liniger, and Gail A Liniger. View insider buying and selling activity for Re/Max.

How do I buy shares of Re/Max?

Shares of RMAX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Re/Max's stock price today?

One share of RMAX stock can currently be purchased for approximately $30.60.

How big of a company is Re/Max?

Re/Max has a market capitalization of $548.05 million and generates $282.29 million in revenue each year. The financial services provider earns $25.04 million in net income (profit) each year or $1.93 on an earnings per share basis. Re/Max employs 500 workers across the globe.

What is Re/Max's official website?

The official website for Re/Max is www.remax.com.

How can I contact Re/Max?

Re/Max's mailing address is 5075 SOUTH SYRACUSE STREET, DENVER CO, 80237. The financial services provider can be reached via phone at 303-770-5531 or via email at [email protected]

This page was last updated on 7/11/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.